BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28034498)

  • 1. Genomic sequencing and precision medicine in head and neck cancers.
    Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
    Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
    Giefing M; Wierzbicka M; Szyfter K; Brenner JC; Braakhuis BJ; Brakenhoff RH; Bradford CR; Sorensen JA; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
    Eur J Cancer; 2016 Mar; 55():147-57. PubMed ID: 26851381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the genomic landscape of head and neck cancers through next-generation sequencing.
    Rizzo G; Black M; Mymryk JS; Barrett JW; Nichols AC
    Oral Dis; 2015 Jan; 21(1):e11-24. PubMed ID: 24725020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing the head and neck cancer genome: implications for therapy.
    Sun W; Califano JA
    Ann N Y Acad Sci; 2014 Dec; 1333():33-42. PubMed ID: 25440877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
    Solis RN; Silverman DA; Birkeland AC
    Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in early diagnosis of head and neck cancer in precision medicine era].
    Min MK; Zhu MH; Zheng HL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(22):1770-1774. PubMed ID: 29798197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging Genomics for Head and Neck Cancer Treatment.
    Kemmer JD; Johnson DE; Grandis JR
    J Dent Res; 2018 Jun; 97(6):603-613. PubMed ID: 29420101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.
    Choonoo G; Blucher AS; Higgins S; Boardman M; Jeng S; Zheng C; Jacobs J; Anderson A; Chamberlin S; Evans N; Vigoda M; Cordier B; Tyner JW; Kulesz-Martin M; McWeeney SK; Laderas T
    PLoS One; 2019; 14(10):e0223639. PubMed ID: 31596908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.
    Nichols AC; Black M; Yoo J; Pinto N; Fernandes A; Haibe-Kains B; Boutros PC; Barrett JW
    BMC Pharmacol Toxicol; 2014 Nov; 15():66. PubMed ID: 25428177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.
    Tillman BN; Yanik M; Birkeland AC; Liu CJ; Hovelson DH; Cani AK; Palanisamy N; Carskadon S; Carey TE; Bradford CR; Tomlins SA; McHugh JB; Spector ME; Brenner JCh
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1646-52. PubMed ID: 26849095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics and precision surgery for head and neck squamous cell carcinoma.
    Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
    Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
    Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
    JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is biomarker research advancing in the era of personalized medicine for head and neck cancer?
    Yokota T
    Int J Clin Oncol; 2014 Apr; 19(2):211-9. PubMed ID: 24442754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
    Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
    Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of head and neck squamous cell carcinoma.
    Saada-Bouzid E; Peyrade F; Guigay J
    Curr Opin Oncol; 2019 May; 31(3):131-137. PubMed ID: 30893149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
    Bozec A; Peyrade F; Milano G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.
    Xu C; Nikolova O; Basom RS; Mitchell RM; Shaw R; Moser RD; Park H; Gurley KE; Kao MC; Green CL; Schaub FX; Diaz RL; Swan HA; Jang IS; Guinney J; Gadi VK; Margolin AA; Grandori C; Kemp CJ; Méndez E
    Clin Cancer Res; 2018 Jun; 24(12):2828-2843. PubMed ID: 29599409
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
    Hammerman PS; Hayes DN; Grandis JR
    Cancer Discov; 2015 Mar; 5(3):239-44. PubMed ID: 25643909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.